Can-Fite's Drugs' Potential Ability to Treat Cytokine Release Syndrome in Cancer Immunotherapy Published in Scientific Journal - Business Wire

Can-Fite's Drugs' Potential Ability to Treat Cytokine Release Syndrome in Cancer Immunotherapy Published in Scientific Journal  Business Wire

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that addre.